Survivin expression was positively linked to the extent of cisplatin-resistance in prostate cancer cells, and survivin inhibitor (gambogic acid) might reverse the chemoresistance of gastric cancer cells to docetaxel [9, 54]. This evidence concerns the gene BIRC5 and prostate cancer.